Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-064148
Filing Date
2025-06-30
Accepted
2025-06-30 16:30:31
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2519495-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2519495-1_4seq1.xml 4 5780
  Complete submission text file 0001104659-25-064148.txt   7200
Mailing Address 7550 WISCONSIN AVENUE 9TH FLOOR BETHESDA MD 20814
Business Address
MACK DAVID J. (Reporting) CIK: 0001694466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 251092505

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)